Literature DB >> 20522000

AMPK inhibition in health and disease.

Benoit Viollet1, Sandrine Horman, Jocelyne Leclerc, Louise Lantier, Marc Foretz, Marc Billaud, Shailendra Giri, Fabrizio Andreelli.   

Abstract

All living organisms depend on dynamic mechanisms that repeatedly reassess the status of amassed energy, in order to adapt energy supply to demand. The AMP-activated protein kinase (AMPK) alphabetagamma heterotrimer has emerged as an important integrator of signals managing energy balance. Control of AMPK activity involves allosteric AMP and ATP regulation, auto-inhibitory features and phosphorylation of its catalytic (alpha) and regulatory (beta and gamma) subunits. AMPK has a prominent role not only as a peripheral sensor but also in the central nervous system as a multifunctional metabolic regulator. AMPK represents an ideal second messenger for reporting cellular energy state. For this reason, activated AMPK acts as a protective response to energy stress in numerous systems. However, AMPK inhibition also actively participates in the control of whole body energy homeostasis. In this review, we discuss recent findings that support the role and function of AMPK inhibition under physiological and pathological states.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20522000      PMCID: PMC3132561          DOI: 10.3109/10409238.2010.488215

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  223 in total

1.  Chronic rosiglitazone treatment restores AMPKalpha2 activity in insulin-resistant rat skeletal muscle.

Authors:  Sarah J Lessard; Zhi-Ping Chen; Matthew J Watt; Michael Hashem; Julianne J Reid; Mark A Febbraio; Bruce E Kemp; John A Hawley
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-08-23       Impact factor: 4.310

2.  Hypothalamic AMP-activated protein kinase mediates counter-regulatory responses to hypoglycaemia in rats.

Authors:  S-M Han; C Namkoong; P G Jang; I S Park; S W Hong; H Katakami; S Chun; S W Kim; J-Y Park; K-U Lee; M-S Kim
Journal:  Diabetologia       Date:  2005-08-23       Impact factor: 10.122

3.  Does AMP-activated protein kinase couple inhibition of mitochondrial oxidative phosphorylation by hypoxia to calcium signaling in O2-sensing cells?

Authors:  A Mark Evans; Kirsteen J W Mustard; Christopher N Wyatt; Chris Peers; Michelle Dipp; Prem Kumar; Nicholas P Kinnear; D Grahame Hardie
Journal:  J Biol Chem       Date:  2005-09-30       Impact factor: 5.157

4.  Contraction-mediated phosphorylation of AMPK is lower in skeletal muscle of adenylate kinase-deficient mice.

Authors:  Chad R Hancock; Edwin Janssen; Ronald L Terjung
Journal:  J Appl Physiol (1985)       Date:  2005-09-29

5.  High-fat diet feeding impairs both the expression and activity of AMPKa in rats' skeletal muscle.

Authors:  Yi Liu; Qiang Wan; Qingbo Guan; Ling Gao; Jiajun Zhao
Journal:  Biochem Biophys Res Commun       Date:  2005-11-21       Impact factor: 3.575

6.  Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity.

Authors:  Annett Hahn-Windgassen; Veronique Nogueira; Chia-Chen Chen; Jennifer E Skeen; Nahum Sonenberg; Nissim Hay
Journal:  J Biol Chem       Date:  2005-07-15       Impact factor: 5.157

7.  Alpha-lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase.

Authors:  Woo Je Lee; In Kyu Lee; Hyoun Sik Kim; Yun Mi Kim; Eun Hee Koh; Jong Chul Won; Sung Min Han; Min-Seon Kim; Inho Jo; Goo Taeg Oh; In-Sun Park; Jang Hyun Youn; Seong-Wook Park; Ki-Up Lee; Joong-Yeol Park
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-10-13       Impact factor: 8.311

8.  Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance.

Authors:  P A Kern; S Ranganathan; C Li; L Wood; G Ranganathan
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-05       Impact factor: 4.310

9.  Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2.

Authors:  L Abu-Elheiga; M M Matzuk; K A Abo-Hashema; S J Wakil
Journal:  Science       Date:  2001-03-30       Impact factor: 47.728

10.  Topiramate treatment causes skeletal muscle insulin sensitization and increased Acrp30 secretion in high-fat-fed male Wistar rats.

Authors:  Jason J Wilkes; M T Audrey Nguyen; Gautam K Bandyopadhyay; Elizabeth Nelson; Jerrold M Olefsky
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-07-19       Impact factor: 4.310

View more
  159 in total

Review 1.  Evolving Lessons on the Complex Role of AMPK in Normal Physiology and Cancer.

Authors:  Biplab Dasgupta; Rishi Raj Chhipa
Journal:  Trends Pharmacol Sci       Date:  2015-12-20       Impact factor: 14.819

2.  AMP-Activated Protein Kinase Alpha 2 Deletion Induces VSMC Phenotypic Switching and Reduces Features of Atherosclerotic Plaque Stability.

Authors:  Ye Ding; Miao Zhang; Wencheng Zhang; Qiulun Lu; Zhejun Cai; Ping Song; Imoh Sunday Okon; Lei Xiao; Ming-Hui Zou
Journal:  Circ Res       Date:  2016-07-20       Impact factor: 17.367

3.  Optimal control strategies of eradicating invisible glioblastoma cells after conventional surgery.

Authors:  Aurelio A de Los Reyes V; Eunok Jung; Yangjin Kim
Journal:  J R Soc Interface       Date:  2015-05-06       Impact factor: 4.118

4.  Cholinergic receptors play a role in the cardioprotective effects of anesthetic preconditioning: Roles of nitric oxide and the CaMKKβ/AMPK pathway.

Authors:  Yang Yang; Ying Li; Jie Wang; Lei Hong; Shigang Qiao; Chen Wang; Jianzhong An
Journal:  Exp Ther Med       Date:  2020-12-14       Impact factor: 2.447

5.  Growth inhibition of colon cancer cells by compounds affecting AMPK activity.

Authors:  Michael A Lea; Jacob Pourat; Rupali Patel; Charles desBordes
Journal:  World J Gastrointest Oncol       Date:  2014-07-15

6.  Acetylcholine ameliorates endoplasmic reticulum stress in endothelial cells after hypoxia/reoxygenation via M3 AChR-AMPK signaling.

Authors:  Xueyuan Bi; Xi He; Man Xu; Ming Zhao; Xiaojiang Yu; Xingzhu Lu; Weijin Zang
Journal:  Cell Cycle       Date:  2015-06-11       Impact factor: 4.534

7.  AMP-activated protein kinase activation by 5-aminoimidazole-4-carbox-amide-1-β-D-ribofuranoside (AICAR) reduces lipoteichoic acid-induced lung inflammation.

Authors:  Arie J Hoogendijk; Sandra S Pinhanços; Tom van der Poll; Catharina W Wieland
Journal:  J Biol Chem       Date:  2013-01-15       Impact factor: 5.157

8.  Metformin-stimulated AMPK-α1 promotes microvascular repair in acute lung injury.

Authors:  Ming-Yuan Jian; Mikhail F Alexeyev; Paul E Wolkowicz; Jaroslaw W Zmijewski; Judy R Creighton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-04       Impact factor: 5.464

9.  Hepatic Overexpression of CD36 Improves Glycogen Homeostasis and Attenuates High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance.

Authors:  Wojciech G Garbacz; Peipei Lu; Tricia M Miller; Samuel M Poloyac; Nicholas S Eyre; Graham Mayrhofer; Meishu Xu; Songrong Ren; Wen Xie
Journal:  Mol Cell Biol       Date:  2016-10-13       Impact factor: 4.272

10.  5'-AMP-activated protein kinase (AMPK) supports the growth of aggressive experimental human breast cancer tumors.

Authors:  Keith R Laderoute; Joy M Calaoagan; Wan-Ru Chao; Dominc Dinh; Nicholas Denko; Sarah Duellman; Jessica Kalra; Xiaohe Liu; Ioanna Papandreou; Lidia Sambucetti; Laszlo G Boros
Journal:  J Biol Chem       Date:  2014-07-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.